Actively Recruiting
The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients
Led by Yonsei University · Updated on 2025-02-24
60
Participants Needed
1
Research Sites
473 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to investigate the effect of Gliatamin (chonline alphoscerate) on depressive mood in type 2 diabetes patients and demonstrate the impact of improved depressive mood could be influence the patient's quality of life and glycemic control.
CONDITIONS
Official Title
The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Type 2 diabetic patients
- Age 50 years or older
- Glycemic control: HbA1c 10.0% or lower
- Beck Depression Inventory (BDI) score between 10 and less than 30
- Participants able to use contraception if of childbearing potential
- Understands study procedures and voluntarily agrees to participate with written consent
You will not qualify if you...
- Type 1 diabetes, secondary diabetes, or gestational diabetes
- Current treatment for dementia or depression
- Uncontrolled psychiatric disorders
- Beck Depression Inventory (BDI) score 30 or higher
- Heavy alcohol use
- Chronic liver diseases such as hemochromatosis, liver cancer, autoimmune liver disease, cirrhosis, or chronic viral hepatitis
- Allergy or sensitivity to study medication or its components
- Renal failure, moderate or severe renal impairment, or dialysis
- Abnormal liver function tests (AST/ALT over three times the upper normal limit)
- History of alcohol or drug abuse within the past 3 months
- Premenopausal women who are nursing or pregnant
- HIV or AIDS infection
- Chronic pancreatitis or pancreatic cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yonsei University College of Medicine, Department of Internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes Center
Seoul, South Korea, 03722
Actively Recruiting
Research Team
B
Bong-Soo Cha, MD, Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here